EDP167 / Edding Genor Group - LARVOL DELTA

Phase 2 Dose-Finding Study Evaluating the Efficacy and Safety of EDP167 in Adults With Mixed Dyslipidemia (clinicaltrials.gov) - P2 | N=144 | Not yet recruiting | Sponsor: Eddingpharm (Zhuhai) Co., Ltd.

New P2 trial • Dyslipidemia • Metabolic Disorders • Mixed Hyperlipidemia • APOB

A Dose-exploration Study of EDP167 in HoFH (clinicaltrials.gov) - P2 | N=20 | Recruiting | Sponsor: Eddingpharm (Zhuhai) Co., Ltd.

New P2 trial • Dyslipidemia • Familial Hypercholesterolemia • Genetic Disorders • Homozygous Familial Hypercholesterolemia • Metabolic Disorders • APOB

EDP167 in Healthy Volunteers and Subjects With Mild Dyslipidemia (clinicaltrials.gov) - P1 | N=40 | Completed | Sponsor: Eddingpharm (Zhuhai) Co., Ltd.

First-in-human • New P1 trial • Dyslipidemia • Metabolic Disorders • APOB